Literature DB >> 28653226

Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.

Mehmet Taşdemir1, Dilara Fuçucuoğlu2, Suat Hayri Küçük3, Meltem Erol2, Özgül Yiğit2, Ilmay Bilge4.   

Abstract

BACKGROUND: To investigate relationships among urinary biomarkers [kidney injury molecule-1 (KIM-1), N-acetyl-β-glucosaminidase (NAG)], neutrophil gelatinase-associated lipocalin (NGAL) levels and renal tubular injury in childhood urolithiasis.
METHODS: Seventy children [36 girls, mean age: 7.3 ± 5.0 years (0.5-18.2)] with urolithiasis/microlithiasis and 42 controls [18 girls, mean age: 8.5 ± 3.8 years (0.9-16.2)] were included in this multicenter, controlled, prospective cohort study. Patients were evaluated three times in 6-month intervals (0, 6 and 12th months). Anthropometric data, urinary symptoms, family history and diagnostic studies were recorded. Urine samples were analyzed for metabolic risk factors (urinary calcium, uric acid, oxalate, citrate, cystine, magnesium, and creatinine excretion), and the urinary KIM-1, NAG, and NGAL levels were measured.
RESULTS: Stones were mostly located in the upper urinary system (82.9%), and six patients (8.6%) had hydronephrosis. Thirty patients (42.9%) had several metabolic risk factors, and the most common metabolic risk factor was hypocitraturia (22.9%). Urinary KIM-1/Cr, NAG/Cr and NGAL/Cr ratios were not significantly different between patients and controls. Furthermore, no significant changes in their excretion were shown during follow-up. Notably, the urinary KIM-1/Cr, NAG/Cr, and NGAL/Cr levels were significantly higher in children under 2 years of age (p = 0.011, p = 0.006, and 0.015, respectively). NAG/Cr and NGAL/Cr ratios were significantly increased in patients with hydronephrosis (n = 6, p = 0.031 and 0.023, respectively).
CONCLUSIONS: The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis.

Entities:  

Keywords:  Biomarkers; Kidney injury molecule-1; Kidney stone disease; Metabolic abnormalities; N-acetyl-β-glucosaminidase; Neutrophil gelatinase-associated lipocalin

Mesh:

Substances:

Year:  2017        PMID: 28653226     DOI: 10.1007/s10157-017-1436-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  42 in total

Review 1.  Renal stone disease.

Authors:  Charles P McKay
Journal:  Pediatr Rev       Date:  2010-05

2.  Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population.

Authors:  V Matos; G van Melle; O Boulat; M Markert; C Bachmann; J P Guignard
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

3.  Increasing incidence of kidney stones in children evaluated in the emergency department.

Authors:  David J Sas; Thomas C Hulsey; Ibrahim F Shatat; John K Orak
Journal:  J Pediatr       Date:  2010-04-01       Impact factor: 4.406

4.  N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation.

Authors:  P Winter; K Ganter; D Heimbach; A Hesse
Journal:  Scand J Urol Nephrol       Date:  1996-12

5.  High incidence of kidney stones in Icelandic children.

Authors:  Vidar Edvardsson; Helga Elidottir; Olafur S Indridason; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2005-05-24       Impact factor: 3.714

6.  Evaluation of urinary KIM-1, NGAL, and IL-18 levels in determining early renal injury in pediatric cases with hypercalciuria and/or renal calculi.

Authors:  Yasar Kandur; Sevim Gonen; Kibriya Fidan; Oguz Soylemezoglu
Journal:  Clin Nephrol       Date:  2016-08       Impact factor: 0.975

7.  Urolithiasis in pediatric patients.

Authors:  D S Milliner; M E Murphy
Journal:  Mayo Clin Proc       Date:  1993-03       Impact factor: 7.616

8.  Tubular kidney injury molecule-1 in protein-overload nephropathy.

Authors:  Mirjan M van Timmeren; Stephan J L Bakker; Vishal S Vaidya; Veronique Bailly; Theo A Schuurs; Jeffrey Damman; Coen A Stegeman; Joseph V Bonventre; Harry van Goor
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-07

9.  Epidemiology of paediatric renal stone disease in the UK.

Authors:  R J M Coward; C J Peters; P G Duffy; D Corry; M J Kellett; S Choong; W G van't Hoff
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

10.  Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome.

Authors:  Kristy VanDervoort; Jonathan Wiesen; Rachel Frank; Suzanne Vento; Virginia Crosby; Manju Chandra; Howard Trachtman
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  3 in total

1.  Distribution of urinary N-acetyl-beta-D-glucosaminidase and the establishment of reference intervals in healthy adults.

Authors:  Qian Liu; Ruyuan Zong; Huan Li; Xiaoxiao Yin; Mei Fu; Li Yao; Jin Sun; Fumeng Yang
Journal:  J Clin Lab Anal       Date:  2021-03-11       Impact factor: 2.352

2.  Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial.

Authors:  Fatemeh Taheri; Maryam Taheri; Abbas Basiri; Alireza Khoshdel; Fariba Samadian; Sanaz Tavasoli
Journal:  Investig Clin Urol       Date:  2019-10-22

Review 3.  Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction.

Authors:  Satoshi Washino; Keiko Hosohata; Tomoaki Miyagawa
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.